Equities research analysts at Cowen and Company hoisted their target price on shares of athenahealth (NASDAQ:ATHN) from $90.00 to $96.00 in a research note issued to investors on Monday, Analyst Ratings Network.com reports. The firm currently has a “market perform” rating on the stock. Cowen and Company’s price objective would indicate a potential downside of 15.04% from the stock’s previous close.
Shares of athenahealth (NASDAQ: ATHN) traded up 2.48% during mid-day trading on Monday, hitting $113.00. athenahealth has a 52 week low of $56.33 and a 52 week high of $116.18. The stock’s 50-day moving average is currently $91.79. The company has a market cap of $4.160 billion and a P/E ratio of 18378.33.
athenahealth (NASDAQ:ATHN) last released its earnings data on Thursday, July 18th. The company reported ($0.08) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.22 by $0.30. The company had revenue of $149.30 million for the quarter, compared to the consensus estimate of $148.24 million. During the same quarter last year, the company posted $0.24 earnings per share. athenahealth’s revenue was up 44.3% compared to the same quarter last year. athenahealth has set its FY13 guidance at $1.05-$1.15 EPS. On average, analysts predict that athenahealth will post $1.08 earnings per share for the current fiscal year.
A number of other analysts have also recently weighed in on ATHN. Analysts at Lazard Capital Markets downgraded shares of athenahealth from a “buy” rating to a “neutral” rating in a research note to investors on Friday. They noted that the move was a valuation call. Separately, analysts at Raymond James downgraded shares of athenahealth from a “strong-buy” rating to an “outperform” rating in a research note to investors on Wednesday, July 17th. They now have a $120.00 price target on the stock, up previously from $100.00. Finally, analysts at Goldman Sachs Group Inc. reiterated an “overweight” rating on shares of athenahealth in a research note to investors on Friday, July 12th. They now have a $127.00 price target on the stock, up previously from $104.00.
Two equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and five have assigned a buy rating to the company’s stock. athenahealth currently has an average rating of “Hold” and a consensus price target of $96.78.
athenahealth, Inc (NASDAQ: ATHN), is a business services company, which provides ongoing billing, clinical-related, and other related services to its customers.